Case | Age (years) | Sex | BMI (kg/m2) | Time since onset of motor symptoms (years) | modified HY stage | DHS | LEDD (mg) | DADD (mg) | |
---|---|---|---|---|---|---|---|---|---|
onset | Adjustment of antiparkinsonian drugs | ||||||||
1 | 60 | F | 22 | 2.8 | 1 | subacute | improvement | 188 | 188 |
2 | 77 | F | 19 | 3.6 | 2 | subacute | no improvement | 300 | 0 |
3 | 71 | M | 21 | 6.1 | 2 | subacute | no improvement | 700 | 200 |
4 | 70 | M | 22 | 8.5 | 3 | subacute | no improvement | 525 | 225 |
5 | 74 | M | 23 | 15.3 | 4 | subacute | no improvement | 1368 | 120 |
6 | 59 | F | 30 | 0 | 2.5 | chronic | no improvement | 0 | 0 |
7 | 65 | F | 23 | 0.3 | 4 | chronic | improvement | 0 | 0 |
8 | 69 | F | 18 | 2.4 | 2 | chronic | no improvement | 0 | 0 |